Taiwan Semiconductor Manufacturing Co Ltd ( NYSE: TSM) Q4 2024 Earnings Conference Call January 16, 2025 1:00 AM ET Jeff Su - Director, IR Wendell Huang - SVP, Finance & CFO C.C. Wei - Vice Chairman & ...

AngioDynamics' fiscal Q2'25 results exceeded expectations, with Med Tech growing 25% and delivering better gross margins. See ...

Opportunities exist overseas in oil and gas, particularly in underdeveloped regions. Read how investors benefit from a market ...

While 2024 was a record revenue year, it was also a record spending year; spending is growing faster. Read more here.

The ClearBridge Canadian Small Cap Strategy meaningfully outperformed its benchmark in the fourth quarter. Read more here.

MARA Holdings, with the second-largest Bitcoin treasury and largest mining operation, mirrors MicroStrategy’s model. Read why ...

Aehr Test Systems' cutting-edge test systems for EV and AI chips face challenges in 2024 but show promise with recent orders ...

We recommend holding Target Hospitality stock with a limited growth potential and a fair value estimate of $10 per share. See ...

Carvana's turnaround is overshadowed by its inflated valuation and questionable financial practices. Read why it's best to ...

GE HealthCare Technologies is showing bullish price action and potential for a bullish turn in momentum, making it a ...

Latin America’s aggregate growth will slightly accelerate in 2025, but this overshadows slower growth across most countries.

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.